PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX-100 trial advances following successful Phase 1b, page-404

  1. 4,336 Posts.
    lightbulb Created with Sketch. 2023
    https://endpts.com/in-a-fresh-disappointment-amgen-spotlights-a-major-safety-issue-with-kras-combo/

    Other kras news
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.